SLC2A2 and neonatal diabetes mellitus: The intriguing fact is that not all cases of FBS patients develop transient neonatal diabetes mellitus and this suggests that there are other molecular mechanisms associated with the onset of the neonatal diabetes that may not be directly related to GLUT2.